13 results found.

Diabetic Nephropathy Clinical Trial using Repository Corticotropin Injection; Placebo

Questcor Pharmaceuticals, Inc. - Recruiting 18 years or older.
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive Design Pilot Safety and Efficacy Study of H.P. Acthar Gel (Acthar) in Patients With Diabetic Nephropathy and Proteinuria..
Repository Corticotropin Injection; Placebo

Diabetic Nephropathies Clinical Trial using BAY94-8862; Placebo

Bayer - Recruiting 18 years or older.
- A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy.
BAY94-8862; Placebo

Diabetic Nephropathies Clinical Trial using BAY94-8862; Placebo; BAY 94-8862

Bayer - Recruiting 18 years or older.
- A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy.
BAY94-8862; Placebo; BAY 94-8862

Diabetic Nephropathy Clinical Trial using Calcitriol; Placebo

Seoul National University Hospital - Recruiting 19 years to 80 years.
- .
Calcitriol; Placebo

Diabetic Nephropathy Clinical Trial using MT-3995-Low; MT-3995-High; Placebo

Mitsubishi Tanabe Pharma Corporation - Recruiting 20 years to 75 years.
- A Phase II, Randomised, Double-blind, Placebo-controlled Study of MT-3995 in Subjects With Diabetic Nephropathy.
MT-3995-Low; MT-3995-High; Placebo

Nervous System, Diabetic Kidney Disease, or Diabetes Mellitus, Ty Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Determinants of Diabetic Nephropathy in American Indians.

Anemia Clinical Trial using methoxy polyethylene glycol-epoetin beta [Mircera]

Hoffmann-La Roche - Recruiting 18 years or older.
- A Single Arm Open Label Multicenter Interventional Study to Assess the Efficacy, Safety, and Tolerability of Every 4 Weeks Administration of Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anaemia in Diabetic Nephropathy With CKD Stages III-IV Not on Dialysis, Not Currently Treated With ESA..
methoxy polyethylene glycol-epoetin beta [Mircera]

Diabetic Nephropathy Clinical Trial using Placebo; LY3016859

Eli Lilly and Company - Recruiting 18 years to 75 years.
- Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients.
Placebo; LY3016859

Diabetic Nephropathy Clinical Trial using PF-04634817; Placebo

Pfizer - Recruiting 18 years or older.
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study To Evaluate The Efficacy And Safety Of Once-Daily Administration Of A Chemokine CCR2/5 Receptor Antagonist (PF-04634817) In Adults With Type 2 Diabetes And Overt Nephropathy.
PF-04634817; Placebo

Diabetic Nephropathy Clinical Trial using colchicine 0.5mg/d; placebo 0.5mg/d

Chongqing Medical University - Recruiting 30 years to 70 years.
- Low-dose Colchicine Intervention in Patients With Type 2 Diabetes Mellitus and Microalbuminuria: Chongqing Study.
colchicine 0.5mg/d; placebo 0.5mg/d

Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial using GKT137831; Placebo

Genkyotex Innovation SAS - Recruiting 18 years to 80 years.
- A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria.
GKT137831; Placebo

Diabetic Nephropathy Clinical Trial using Atrasentan; Placebo

AbbVie - Recruiting 18 years to 85 years.
- A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan.
Atrasentan; Placebo

Diabetic Nephropathy Clinical Trial using colchicine

Sheba Medical Center - Recruiting 18 years to 90 years.
- Colchicine for Diabetic Nephropathy.
colchicine